Japanese Journal of Clinical Oncology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Lecture No. 4 Cancer care in Asia from the perspective of latest developments in the US pharmaceutical industry
cross-boundary cancer studiesthe University of TokyoUICCUHCcancer care cost in Asiadigital health and medication (Source: Japanese Journal of Clinical Oncology)
Source: Japanese Journal of Clinical Oncology - May 18, 2021 Category: Cancer & Oncology Source Type: research

Lecture No. 1 What significance do universities have in the era of digital knowledge?
cross-boundary cancer studiesthe University of TokyoUICCUHC-scales of history-generation interval (Source: Japanese Journal of Clinical Oncology)
Source: Japanese Journal of Clinical Oncology - May 18, 2021 Category: Cancer & Oncology Source Type: research

Lecture No. 7 Asia Health and Wellbeing Initiative (AHWIN) and implementation of cancer genomic medicine in Asian countries
cross-boundary cancer studiesthe University of TokyoUICCUHCAHWINcancer genomic medicine (Source: Japanese Journal of Clinical Oncology)
Source: Japanese Journal of Clinical Oncology - May 18, 2021 Category: Cancer & Oncology Source Type: research

Lecture No. 5Impact of Human Genome Research: ‘Policy and Ethics’—its meaning in data sharing
cross-boundary cancer studiesthe University of TokyoUICCUHChuman genome researchmedical research policy and ethics (Source: Japanese Journal of Clinical Oncology)
Source: Japanese Journal of Clinical Oncology - May 18, 2021 Category: Cancer & Oncology Source Type: research

Foreword —Engaging in Multisectoral Approaches Towards Achieving UHC
I am delighted to introduce this University of Tokyo lecture series on ‘Is UHC for cancer in Asia an achievable goal?’, supported by the Union for International Cancer Control (UICC) Asia Regional Office (UICC-ARO). Globally, the cancer burden continues to grow where recent data released by the International Agency for Research on Cancer (IARC) reports that in 2020 , there were an estimated 19.3 million new cases and 10 million deaths. A further increase in the cancer burden is predicted between 2020 and 2040, of which IARC estimates that half is due to changing demographics alone. (IARC press release 292.https://www.i...
Source: Japanese Journal of Clinical Oncology - May 18, 2021 Category: Cancer & Oncology Source Type: research

Lecture No. 10 AI and telemedicine: how is technology transforming the horizons for global health?
cancer typeSoutheast Asiaprecision medicinepathological diagnosistelepathologymolecular epidemiologyincome level and cancer subtype (Source: Japanese Journal of Clinical Oncology)
Source: Japanese Journal of Clinical Oncology - May 18, 2021 Category: Cancer & Oncology Source Type: research

Foreword – A Decade of Cross-Boundary Cooperation: UICC-ARO and the University of Tokyo
I would like to begin by expressing my congratulations to the University of Tokyo on the publication of this collection of articles based on the lecture series ‘Is UHC for cancer in Asia an achievable goal?’. The lecture series was supported by the Union for International Cancer Control Asia Regional Office (UICC-ARO), and its publication and dissemination to a wider audience will be most significant in efforts to further raise the standards of cancer care in Asia in the future. (Source: Japanese Journal of Clinical Oncology)
Source: Japanese Journal of Clinical Oncology - May 18, 2021 Category: Cancer & Oncology Source Type: research

Lecture No. 11 What are the benefits of patient engagement and local community health?
cross-boundary cancer studiesthe University of TokyoUICCUHCpatient engagementlocal community health (Source: Japanese Journal of Clinical Oncology)
Source: Japanese Journal of Clinical Oncology - May 18, 2021 Category: Cancer & Oncology Source Type: research

Extraordinary nature of lecture series on cancer studies at the University of Tokyo
When I was in charge of promotion of global education at the University of Tokyo between 2015 and 2017, I attended a lot of international conferences on higher education, where I heard the voices that interdisciplinary classes and courses are necessary at the graduate-level programs in order to cultivate students who can solve the complicated global issues, including pandemic, environmental protection, social inequality and so on. At the same time, however, I also heard the claims that developing and maintaining interdisciplinary classes and courses are extremely difficult no matter where these classes and courses are deve...
Source: Japanese Journal of Clinical Oncology - May 18, 2021 Category: Cancer & Oncology Source Type: research

Lecture No. 8What can public –private partnerships achieve for cancer treatment in Asia?
cross-boundary cancer studiesthe University of TokyoUICCUHCpharmaceutical industryAccess Accelerated (Source: Japanese Journal of Clinical Oncology)
Source: Japanese Journal of Clinical Oncology - May 18, 2021 Category: Cancer & Oncology Source Type: research

The new significance of UHC for cancer in Asia in the era of data-driven cancer research
cross-boundary cancer studiesthe University of TokyoUICCUHCData-driven Cancer Research (Source: Japanese Journal of Clinical Oncology)
Source: Japanese Journal of Clinical Oncology - May 18, 2021 Category: Cancer & Oncology Source Type: research

Surviving cancer in Asia: cross-boundary cancer studies, University of Tokyo
The international community faces a lot of challenges relating to cancer treatment and care. Even a simple glance at the status of medical care around the world makes it clear that economic disparities correlate directly to differences in medical care systems, which in turn generate medical disparities. Needless to say, these ever-increasing disparities in cancer care are an urgent challenge that the entire world needs to address decisively. (Source: Japanese Journal of Clinical Oncology)
Source: Japanese Journal of Clinical Oncology - May 18, 2021 Category: Cancer & Oncology Source Type: research

Lecture No. 6 Asia Health and Wellbeing Initiative (AHWIN) and cancer
cross-boundary cancer studiesthe University of TokyoUICCUHC-Asia Health and Wellbeing Initiative (AHWIN)-G20 (Source: Japanese Journal of Clinical Oncology)
Source: Japanese Journal of Clinical Oncology - May 18, 2021 Category: Cancer & Oncology Source Type: research

Lecture No. 3 Current status and future outlook for collection of cancer-related data in Asia
cross-boundary cancer studiesthe University of TokyoUICCUHCstatisticsAsia (Source: Japanese Journal of Clinical Oncology)
Source: Japanese Journal of Clinical Oncology - May 18, 2021 Category: Cancer & Oncology Source Type: research

Lecture No. 2 Is UHC for cancer in Asia an achievable goal?
(Source: Japanese Journal of Clinical Oncology)
Source: Japanese Journal of Clinical Oncology - May 18, 2021 Category: Cancer & Oncology Source Type: research